Copyright
©The Author(s) 2022.
World J Clin Cases. Jul 6, 2022; 10(19): 6587-6594
Published online Jul 6, 2022. doi: 10.12998/wjcc.v10.i19.6587
Published online Jul 6, 2022. doi: 10.12998/wjcc.v10.i19.6587
Parameter | Recorded value | Reference range |
White blood cell count (× 109/L) | 5.22 | 4.0-10.0 |
Red blood cell count (× 1012/L) | 2.29 | 4.0-5.5 |
Hemoglobin (g/L) | 65 | 120-160 |
Platelet count (× 109/L) | 146 | 100-300 |
Hematocrit (%) | 22 | 38.0-50.8 |
Mean corpuscular volume (fl) | 95.9 | 80-100 |
Mean corpuscular hemoglobin (pg) | 29.1 | 27-31 |
Mean corpuscular hemoglobin concentration (g/L) | 304 | 320-360 |
Reticulocyte count (× 1012/L) | 0.079 | 0.024-0.084 |
Reticulocyte percentage (%) | 3.45 | 0.5-1.5 |
Iron (μmol/L) | 7.68 | 10.6-36.7 |
Serum ferritin (μg/L) | 345 | 30-300 |
Total iron binding capacity (μmol/L) | 26.51 | 45-75 |
Transferrin saturation (%) | 19.9 | 20-50 |
C-reactive protein (mg/L) | 15.41 | < 10 |
Albumin (g/L) | 24.4 | 40.0-55.0 |
Calcium (mmol/L) | 2.01 | 2.11-2.52 |
Phosphonium (mmol/L) | 1.58 | 0.85-1.51 |
Intact parathyroid hormone (pg/ml) | 27.3 | 150-300 |
Blood urea nitrogen (mmol/L) | 21.66 | 3.6-9.5 |
Serum creatinine (μmol/L) | 556 | 57.0-111.0 |
EPO concentration (mIU/ml) | 28.6 | 4.3-29 |
Direct Coombs (IgG, C3) tests | Negative | Negative |
Anti-EPO antibodies | Negative | Negative |
Fecal occult blood test | Negative | Negative |
- Citation: Zhou QQ, Li J, Liu B, Wang CL. Roxadustat for treatment of anemia in a cancer patient with end-stage renal disease: A case report. World J Clin Cases 2022; 10(19): 6587-6594
- URL: https://www.wjgnet.com/2307-8960/full/v10/i19/6587.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i19.6587